Showing results (71-80 of 88) with videos related to
Sort By:
Pageof 9
The New England Journal of Medicine|July 12, 2014
Assessment of second-line antiretroviral regimens for HIV therapy in AfricaNicholas I Paton, Cissy Kityo, Anne Hoppe, et al.Open Forum Infectious Diseases|November 2, 2016
Continued Elevation of Interleukin-18 and Interferon-γ After Initiation of Antiretroviral Therapy and Clinical Failure in a Diverse Multicountry Human Immunodeficiency Virus CohortAshwin Balagopal, Nikhil Gupte, Rupak Shivakoti, et al.Journal of Neurovirology|July 26, 2011
A multinational study of neurological performance in antiretroviral therapy-naïve HIV-1-infected persons in diverse resource-constrained settingsKevin Robertson, Johnstone Kumwenda, Khuanchai Supparatpinyo, et al.The New England Journal of Medicine|March 14, 2019
One Month of Rifapentine plus Isoniazid to Prevent HIV-Related TuberculosisSusan Swindells, Ritesh Ramchandani, Amita Gupta, et al.BMC Infectious Diseases|January 15, 2021
ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosingCecilia L Moore, Anna Turkova, Hilda Mujuru, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|May 29, 2015
Pre-cART Elevation of CRP and CD4+ T-Cell Immune Activation Associated With HIV Clinical Progression in a Multinational Case-Cohort StudyAshwin Balagopal, David M Asmuth, Wei-Teng Yang, et al.Lancet (London, England)|March 31, 2016
Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trialMina C Hosseinipour, Gregory P Bisson, Sachiko Miyahara, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 24, 2018
Human Immunodeficiency Virus Type 1 and Tuberculosis Coinfection in Multinational, Resource-limited Settings: Increased Neurological DysfunctionKevin R Robertson, Bibilola Oladeji, Hongyu Jiang, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 15, 2015
Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical TrialRami Kantor, Laura Smeaton, Saran Vardhanabhuti, et al.The New England Journal of Medicine|October 15, 2010
Antiretroviral therapies in women after single-dose nevirapine exposureShahin Lockman, Michael D Hughes, James McIntyre, et al.Pageof 9